News & Press
Bioness Medical Announces 510(k) Clearance for PoNS® (Portable Neuromodulation Stimulator) to Manage Patients Recovering from Stroke
CSV Import6/29/2026·06/29/26🌐 USA
Why it matters
Expanding PoNS from multiple sclerosis to stroke rehabilitation broadens the addressable patient population for tongue-based neurostimulation, and signals regulators' growing comfort with non-invasive neurorehabilitation devices.
#Neuromodulation#Neurostimulation#Stroke#FDA Approved
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in